Table 1 Comparison of the baseline characteristics of patients who underwent total gastrectomy (n = 75)

Sex (men/women)

22/4

35/14

0.20

Age (mean ± SD)

70.8 ± 9.7

70.7 ± 10.2

0.71

ASA (I/II/III)

7/15/4

6/36/7

0.25

BMI (kg/m²) in mean ± SD

25.1 ± 3.0 (20.0–32.2)

20.8 ± 2.6 (14.7–25.4)

<0.0001

VFA (cm²) (mean ± SD)

146.9 ± 38.2 (101.8–240.9)

54.3 ± 27.1 (5.9–99.9)

<0.0001

SFA (cm²) (mean ± SD)

157.1 ± 54.8 (77.3–292.3)

86.1 ± 54.9 (5.1–200.5)

<0.0001

Total fat area (cm²) (mean ± SD)

304.0 ± 74.7 (194.7–481.2)

140.5 ± 72.0 (14.3–286.0)

<0.0001

Diabetes mellitus

7

7

0.18

Cardiac history

5

8

0.75

Pulmonary history

1

3

0.68

Chronic kidney disease

4

0

0.005

Pathologic T (1a/1b/2/3/4a/4b)

1/7/7/4/7/0

2/6/9/20/10/2

0.19

Pathologic N (0/1/2/3)

12/4/3/7

17/6/13/13

0.48

Pathologic M (0/1)

26/1

44/5

0.33

Pathologic stage (I/II/III/IV)

11/6/8/1

14/10/20/5

0.51

Neoadjuvant chemotherapy

0

3

0.198

Residual gastrectomy

0

6

0.06

Splenectomy

8

10

0.32

Resection of pancreatic tail

1

2

0.24

Partial resection of colon

1

1

0.64